| Jeffery S Clemons, PT | |
|
2002 12th Ave Nw, Ste A, Ardmore, OK 73401-1227 | |
| (580) 226-9235 | |
| (580) 226-9239 |
| Full Name | Jeffery S Clemons |
|---|---|
| Gender | Male |
| Speciality | Physical Therapist |
| Location | 2002 12th Ave Nw, Ardmore, Oklahoma |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639186943 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 2801 (Oklahoma) | Primary |
| Provider Name | Excel-ardmore Llc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1730251620 PECOS PAC ID: 7810095437 Enrollment ID: O20070606000022 |
News Archive
Comprehensive Care Corporation, a leading behavioral health, substance abuse and pharmacy management provider for employers, Taft-Hartley health and welfare funds, and managed care companies, today announced that it has entered into an agreement with Upstate Financial Service/ John Argiro (collectively, "Mr. Argiro"), a leading consulting firm in healthcare to local and national unions, municipalities and private-sector groups.
Over the past few years, MIT engineers have successfully tested robotic devices to help stroke patients learn to control their arms and legs. Now, they're building on that work to help children with cerebral palsy.
Tarix Pharmaceuticals today announced that it's drug, TXA127, has been granted Orphan Drug designation from the U.S. Food and Drug Administration (FDA) as a treatment to enhance engraftment in patients receiving a stem cell transplant. TXA127 has also received Orphan Drug designation for the treatment of Myelodysplastic Syndrome (MDS).
Customizing targeted therapies to each tumor's molecular characteristics, instead of a one-size-fits-all approach by tumor type, may be more effective for some types of cancer, according to research conducted by The University of Texas MD Anderson Cancer Center.
Foamix Ltd., a leading developer of topical foams for dermatological and gynecological use, announced today that it has been awarded Mexican Patent Registration No. 268451 entitled "Cosmetic and Pharmaceutical Foam." The patent covers Foamix's vehicles, compositions and cosmetic and pharmaceutical uses thereof based on the company's Emollient Foam technology platform.
› Verified 6 days ago
| Provider Name | Select Physical Therapy Holdings Inc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1205162716 PECOS PAC ID: 9537076401 Enrollment ID: O20110106000736 |
News Archive
Comprehensive Care Corporation, a leading behavioral health, substance abuse and pharmacy management provider for employers, Taft-Hartley health and welfare funds, and managed care companies, today announced that it has entered into an agreement with Upstate Financial Service/ John Argiro (collectively, "Mr. Argiro"), a leading consulting firm in healthcare to local and national unions, municipalities and private-sector groups.
Over the past few years, MIT engineers have successfully tested robotic devices to help stroke patients learn to control their arms and legs. Now, they're building on that work to help children with cerebral palsy.
Tarix Pharmaceuticals today announced that it's drug, TXA127, has been granted Orphan Drug designation from the U.S. Food and Drug Administration (FDA) as a treatment to enhance engraftment in patients receiving a stem cell transplant. TXA127 has also received Orphan Drug designation for the treatment of Myelodysplastic Syndrome (MDS).
Customizing targeted therapies to each tumor's molecular characteristics, instead of a one-size-fits-all approach by tumor type, may be more effective for some types of cancer, according to research conducted by The University of Texas MD Anderson Cancer Center.
Foamix Ltd., a leading developer of topical foams for dermatological and gynecological use, announced today that it has been awarded Mexican Patent Registration No. 268451 entitled "Cosmetic and Pharmaceutical Foam." The patent covers Foamix's vehicles, compositions and cosmetic and pharmaceutical uses thereof based on the company's Emollient Foam technology platform.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jeffery S Clemons, PT 2232 W Houston St, Broken Arrow, OK 74012-3529 Ph: (918) 259-9522 | Jeffery S Clemons, PT 2002 12th Ave Nw, Ste A, Ardmore, OK 73401-1227 Ph: (580) 226-9235 |
News Archive
Comprehensive Care Corporation, a leading behavioral health, substance abuse and pharmacy management provider for employers, Taft-Hartley health and welfare funds, and managed care companies, today announced that it has entered into an agreement with Upstate Financial Service/ John Argiro (collectively, "Mr. Argiro"), a leading consulting firm in healthcare to local and national unions, municipalities and private-sector groups.
Over the past few years, MIT engineers have successfully tested robotic devices to help stroke patients learn to control their arms and legs. Now, they're building on that work to help children with cerebral palsy.
Tarix Pharmaceuticals today announced that it's drug, TXA127, has been granted Orphan Drug designation from the U.S. Food and Drug Administration (FDA) as a treatment to enhance engraftment in patients receiving a stem cell transplant. TXA127 has also received Orphan Drug designation for the treatment of Myelodysplastic Syndrome (MDS).
Customizing targeted therapies to each tumor's molecular characteristics, instead of a one-size-fits-all approach by tumor type, may be more effective for some types of cancer, according to research conducted by The University of Texas MD Anderson Cancer Center.
Foamix Ltd., a leading developer of topical foams for dermatological and gynecological use, announced today that it has been awarded Mexican Patent Registration No. 268451 entitled "Cosmetic and Pharmaceutical Foam." The patent covers Foamix's vehicles, compositions and cosmetic and pharmaceutical uses thereof based on the company's Emollient Foam technology platform.
› Verified 6 days ago
Mercy Memorial Health Center Inc Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 709 N Commerce St, Ardmore, OK 73401 Phone: 580-220-6285 Fax: 580-220-6287 | |
Shane Stovall, RPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1405 4th Ave Nw # 296, Ardmore, OK 73401 Phone: 580-795-4768 | |
Mr. Jim Lee Pitman, PHYSICAL THERAPIST Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2 W Main St, Suite 200, Ardmore, OK 73401 Phone: 580-223-3383 Fax: 580-223-6696 | |
C Mark Fleming, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1405 4th Ave Nw # 296, Ardmore, OK 73401 Phone: 580-223-6448 Fax: 580-223-6448 | |
Joel Nedley, Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1405 4th Ave Nw # 296, Ardmore, OK 73401 Phone: 580-226-5566 | |
Home Mods By Therapists, Llc Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 3424 Mount Washington Rd, Ardmore, OK 73401 Phone: 580-221-3950 | |
Imc Of Oklahoma, Llc Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1105 Michelin Rd, Ardmore, OK 73401 Phone: 580-224-4446 |